Connect Biopharma Holdings Limited Ordinary Shares
Symbol: CNTB (NASDAQ)
1.63
▲ (0.62%) 0.010
Company Description:
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
Key Stats
- Today's Open: $1.62
- Today's High: $1.69
- Today's Low: $1.6
- Today's Volume: 31.88K
- Yesterday Close: $1.62
- Yesterday High: $1.65
- Yesterday Low: $1.5601
- Yesterday Volume: 19.11K
- Last Min Volume: 2
- Last Min High: $1.63
- Last Min Low: $1.63
- Last Min VWAP: $1.63
Company Profile
- Name: Connect Biopharma Holdings Limited Ordinary Shares
- Website: https://www.connectbiopharm.com
- Listed Date: 2025-09-03
- Location: SAN DIEGO, CA
- Market Status: Active
- CIK Number: 0001835268
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $90.28M
- Round Lot: 100
- Outstanding Shares: 55.73M
- Asset Type: CS
RECENT FILINGS FOR CNTB
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-01 | 144 | View |
| 2025-09-16 | 8-K | View |
| 2025-09-12 | EFFECT | View |
| 2025-09-10 | POS AM | View |
| 2025-08-13 | 10-Q | View |
| 2025-08-13 | 8-K | View |
| 2025-07-22 | 8-K | View |
| 2025-07-21 | 8-K | View |
| 2025-07-21 | SCHEDULE 13D/A | View |
| 2025-07-18 | F-6 POS | View |
| 2025-07-17 | 8-K | View |
| 2025-07-09 | 8-K | View |
| 2025-06-26 | EFFECT | View |
| 2025-06-24 | CORRESP | View |
| 2025-06-12 | UPLOAD | View |
| 2025-06-11 | 144 | View |
| 2025-06-10 | S-8 | View |
| 2025-06-10 | F-3 | View |
| 2025-05-15 | 10-Q | View |
| 2025-05-15 | 8-K | View |
Latest News on CNTB